Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1538-1541

  Tsuda, Tatsuya ^a,b   Ishikawa, Chika ^a   Konishi, Hiroe ^a   Hayashi, Yoshiaki ^a   Nakagawa, Noboru ^a   Matsuki, Masato ^a   Mizutani, Hitoshi ^b   Yamanishi, Kiyofumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; JOSAMYCIN; OLEANDOMYCIN; PROTEINASE ACTIVATED RECEPTOR 2; ROXITHROMYCIN; SPIRAMYCIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN;

CELLS, CULTURED; CLARITHROMYCIN; EPIDERMIS; ERYTHROMYCIN; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; KERATINOCYTES; MACROLIDES; RECEPTOR, PAR-2; ROXITHROMYCIN;

EID: 42049104909     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00140-07     Document Type: Article

References (24)

1. Arata, J. 1992. Newer macrolide antibiotics. Jpn. J. Clin. Dermatol. 46:145-150.
2. Buddenkotte, J., C. Stroh, I. H. Engels, C. Moormann, V. M. Shpacovitch, S. Seeliger, N. Vergnolle, D. Vestweber, T. A. Luger, K. Schulze-Osrhoff, and M. Steinhoff. 2005. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B. J. Investig. Dermatol. 124:38-45.
3. Campa, M., I. Zolfino, S. Senesi, N. Bernardini, R. Danesi, M. Ducci, M. Oleggini, R. Di Stefano, F. Mosca, and A. Lazzarini. 1990. The penetration of roxithromycin into human skin. J. Antimicrob. Chemother. 26:87-90.
4. Fujita, K., T. Shimizu, Y. Majima, and Y. Sakakura. 2000. Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells. Eur. Arch. Otorhinolaryngol. 257:199-204.
5. Horiuchi, Y., S. Bae, and I. Katayama. 2006. Uncontrollable prurigo nodularis effectively treated by roxithromycin and tranilast. J. Drugs Dermatol. 5:363-365.
6. Hou, L., S. Kapas, A. T. Cruchley, M. G. Macey, P. Harriott, C. Chinni, S. R. Stone, and G. L. Howells. 1998. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 94:356-362.
7. Iwakiri, K., M. Ghazizadeh, E. Jin, M. Fujiwara, T. Takemura, S. Takezaki, S. Kawana, S. Yasuoka, and O. Kawanami. 2004. Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. J. Investig. Dermatol. 122:937-944.
8. Kawasaki, S., H. Takizawa, T. Ohtoshi, N. Takeuchi, T. Kohyama, H. Nakamura, T. Kasama, K. Kobayashi, K. Nakahara, Y. Morita, and K. Yamamoto. 1998. Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob. Agents Chemother. 42:1499-1502.
9. Komine, M., T. Kakinuma, S. Kagami, Y. Hanakawa, K. Hashimoto, and K. Tamaki. 2005. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Investig. Dermatol. 125:491-498.
10. Komine, M., and K. Tamaki. 2000. An open trial of oral macrolide treatment for psoriasis vulgaris. J. Dermatol. 27:508-512.
11. Komiya, N., and K. Tamaoki. 2001. Therapeutic effects of macrolides on patients with psoriasis vulgaris, pigmentary prurigo, or eosinophilic pustule folliculitis. Jpn. J. Antibiot. 54(Suppl. A):100-102. (In Japanese.)
12. Kudoh, S., A. Azuma, M. Yamamoto, T. Izumi, and M. Ando. 1998. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am. J. Respir. Crit. Care Med. 157:1829-1832.
13. 2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes. Br. J. Pharmacol. 145:535-544.
14. Mitsuyama, T., K. Hidaka, T. Furuno, and N. Hara. 1997. Neutrophil-induced endothelial cell damage: inhibition by a 14-membered-ring macrolide through the action of nitric oxide. Int. Arch. Allergy Immunol. 114:111-115.
15. Oishi, K., F. Sonoda, S. Kobayashi, A. Iwagaki, T. Nagatake, K. Matsushima, and K. Matsumoto. 1994. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect. Immun. 62:4145-4152.
16. Ozawa, M., and S. Aiba. 2004. Immunopathogenesis of psoriasis. Curr. Drug Targets Inflamm. Allergy 3:137-144.
17. Sato, Y., K. Kaneko, and M. Inoue. 2007. Macrolide antibiotics promote the LPS-induced upregulation of prostaglandin E receptor EP2 and thus attenuate macrolide suppression of IL-6 production. Prostaglandins Leukot. Essent. Fatty Acids 76:181-188.
18. Seeliger, S., C. K. Derian, N. Vergnolle, N. W. Bunnett, R. Nawroth, M. Schmelz, P. Y. von der Weid, J. Buddenkotte, C. Sunderkotter, D. Metze, P. Andrade-Gordon, E. Harms, D. Vestweber, T. A. Luger, and M. Steinhoff. 2003. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J. 17:1871-1885.
19. Suzuki, H., A. Shimomura, K. Ikeda, M. Furukawa, T. Oshima, and T. Takasaka. 1997. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 107:1661-1666.
20. Takahashi, H., Y. Hashimoto, A. Ishida-Yamamoto, and H. Iizuka. 2005. Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes. J. Dermatol. Sci. 39:175-182.
21. Takizawa, H., M. Desaki, T. Ohtoshi, S. Kawasaki, T. Kohyama, M. Sato, M. Tanaka, T. Kasama, K. Kobayashi, J. Nakajima, and K. Ito. 1997. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 156:266-271.
22. Vaillant, L., G. Lorette, J. Loulergue, and A. Audurier. 1987. Erythromycin ethyl succinate: diffusion through interstitial dermal fluid. Eur. J. Clin. Pharmacol. 33:529-530.
23. Yazawa, N., H. Ihn, K. Yamane, T. Etoh, and K. Tamaki. 2001. The successful treatment of prurigo pigmentosa with macrolide antibiotics. Dermatology 202:67-69.
24. Zalewska-Kaszubska, J., and D. Gorska. 2001. Anti-inflammatory capabilities of macrolides. Pharmacol. Res. 44:451-454.